ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BRH Braveheart Investment Group Plc

6.35
-0.65 (-9.29%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Braveheart Investment Group Plc LSE:BRH London Ordinary Share GB00B13XV322 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.65 -9.29% 6.35 6.20 6.50 7.00 6.35 7.00 404,663 15:50:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Management Services 51k 1.59M 0.0249 2.55 4.05M

Braveheart Investment Group plc Further re Paraytec Limited (5021O)

01/06/2020 7:00am

UK Regulatory


Braveheart Investment (LSE:BRH)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Braveheart Investment Charts.

TIDMBRH

RNS Number : 5021O

Braveheart Investment Group plc

01 June 2020

1 June 2020

Braveheart Investment Group plc

("Braveheart" or the "Group")

Further re Paraytec Limited

Commencement of the project to develop a COVID-19 test with the University of Sheffield

Further to the announcement dated 6 May 2020, the Company announced that Paraytec Limited ("Paraytec"), a wholly-owned subsidiary of Braveheart, was in discussions with the University of Sheffield and Aptamer Group plc to define a project to develop a rapid test for the pandemic pathogen, COVID-19. These discussions have now successfully concluded, and the project will now commence with Sheffield University, but without the involvement of Aptamer Group plc, today.

The test will utilise a highly sensitive light-based detection system coupled with a molecular "affinity" device to capture COVID-19 virus particles. The required affinity macromolecule (an aptamer which binds to the Spike glycoprotein on the surface of the virus) is now being synthesised for Paraytec by a UK university-based laboratory and will be supplied imminently.

Working with Professor Carl Smythe's group at the University of Sheffield - which has expertise in the field of synthetic bio-molecular sensors - the test will combine the use of the COVID-19 capture aptamer with a biomolecular signal generator configured to emit light in the presence of the pathogen, making it visible to Paraytec's detector.

Paraytec will own all foreground IP generated by the project.

The objective is to develop a portable test, which can generate a result in a matter of minutes from a swab provided at the test location and which requires no specialist skills for its operation. If successful, it could be used in airports, transport hubs, large workplaces and similar settings, where rapid screening of large numbers of people for presence of COVID-19 or any future emerging pandemic, is required.

Professor Smythe holds a personal Chair in Molecular Cell Biology in the Department of Biomedical Science at the University of Sheffield. Formerly Academic Director of the Sheffield Cancer Centre, his research is focused on cellular quality control systems monitoring chromosomal DNA. With 35 years' research experience, he has, together with collaborators in academia and industry, developed a wide range of sensor systems with applications in disease testing.

For further information:

 
 Braveheart Investment Group plc               Tel: 01738 587555 
  Trevor Brown, Chief Executive Officer 
 Allenby Capital Limited (Nominated Adviser    Tel: 020 3328 5656 
  and Joint Broker) 
  David Worlidge / Nicholas Chambers 
 
   Peterhouse Capital Limited (Joint Broker)     Tel: 020 7469 0936 
   Heena Karani / Lucy Williams 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

FURKZGGVKMZGGZG

(END) Dow Jones Newswires

June 01, 2020 02:00 ET (06:00 GMT)

1 Year Braveheart Investment Chart

1 Year Braveheart Investment Chart

1 Month Braveheart Investment Chart

1 Month Braveheart Investment Chart

Your Recent History

Delayed Upgrade Clock